116 related articles for article (PubMed ID: 20817753)
1. Morpholino oligonucleotides do not participate perfectly in standard Watson-Crick complexes with RNA.
Xiao G; Wesolowski D; Izadjoo M; Altman S
RNA; 2010 Nov; 16(11):2218-25. PubMed ID: 20817753
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of expression of several genes in a variety of bacterial species by EGS technology.
Shen N; Ko JH; Xiao G; Wesolowski D; Shan G; Geller B; Izadjoo M; Altman S
Proc Natl Acad Sci U S A; 2009 May; 106(20):8163-8. PubMed ID: 19416872
[TBL] [Abstract][Full Text] [Related]
3. Stability of non-Watson-Crick G-A/A-G base pair in synthetic DNA and RNA oligonucleotides.
Ito Y; Sone Y; Mizutani T
Mol Biol Rep; 2004 Mar; 31(1):31-6. PubMed ID: 15040452
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human cytomegalovirus major capsid protein expression and replication by ribonuclease P-associated external guide sequences.
Deng Q; Liu Y; Li X; Yan B; Sun X; Tang W; Trang P; Yang Z; Gong H; Wang Y; Lu J; Chen J; Xia C; Xing X; Lu S; Liu F
RNA; 2019 May; 25(5):645-655. PubMed ID: 30803999
[TBL] [Abstract][Full Text] [Related]
5. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
Deere J; Iversen P; Geller BL
Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
[TBL] [Abstract][Full Text] [Related]
6. Targeted cleavage of mRNA in vitro by RNase P from Escherichia coli.
Li Y; Guerrier-Takada C; Altman S
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3185-9. PubMed ID: 1373488
[TBL] [Abstract][Full Text] [Related]
7. RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences.
Dunn W; Trang P; Khan U; Zhu J; Liu F
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14831-6. PubMed ID: 11742095
[TBL] [Abstract][Full Text] [Related]
8. Cleavage by RNase P of gene N mRNA reduces bacteriophage lambda burst size.
Li Y; Altman S
Nucleic Acids Res; 1996 Mar; 24(5):835-42. PubMed ID: 8600449
[TBL] [Abstract][Full Text] [Related]
9. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
Bruice TW; Lima WF
Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
[TBL] [Abstract][Full Text] [Related]
10. Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.
Nan Y; Zhang YJ
Front Microbiol; 2018; 9():750. PubMed ID: 29731743
[TBL] [Abstract][Full Text] [Related]
11. Design of short external guide sequences (EGSs) for cleavage of target molecules with RNase P.
Werner M; Rosa E; George ST
Nucleic Acids Symp Ser; 1997; (36):19-21. PubMed ID: 9478194
[TBL] [Abstract][Full Text] [Related]
12. Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.
Tilley LD; Mellbye BL; Puckett SE; Iversen PL; Geller BL
J Antimicrob Chemother; 2007 Jan; 59(1):66-73. PubMed ID: 17079242
[TBL] [Abstract][Full Text] [Related]
13. Important 2'-hydroxyl groups in model substrates for M1 RNA, the catalytic RNA subunit of RNase P from Escherichia coli.
Perreault JP; Altman S
J Mol Biol; 1992 Jul; 226(2):399-409. PubMed ID: 1379304
[TBL] [Abstract][Full Text] [Related]
14. In vitro selection of external guide sequences for directing human RNase P to cleave a target mRNA.
Raj S; Liu F
Methods Mol Biol; 2004; 252():413-24. PubMed ID: 15017067
[TBL] [Abstract][Full Text] [Related]
15. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus.
Deas TS; Bennett CJ; Jones SA; Tilgner M; Ren P; Behr MJ; Stein DA; Iversen PL; Kramer LD; Bernard KA; Shi PY
Antimicrob Agents Chemother; 2007 Jul; 51(7):2470-82. PubMed ID: 17485503
[TBL] [Abstract][Full Text] [Related]
16. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.
Tilley LD; Hine OS; Kellogg JA; Hassinger JN; Weller DD; Iversen PL; Geller BL
Antimicrob Agents Chemother; 2006 Aug; 50(8):2789-96. PubMed ID: 16870773
[TBL] [Abstract][Full Text] [Related]
17. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
Delihas N; Rokita SE; Zheng P
Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
[TBL] [Abstract][Full Text] [Related]
18. How RNase HI (Escherichia coli) promoted site-selective hydrolysis works on RNA in duplex with carba-LNA and LNA substituted antisense strands in an antisense strategy context?
Plashkevych O; Li Q; Chattopadhyaya J
Mol Biosyst; 2017 May; 13(5):921-938. PubMed ID: 28352859
[TBL] [Abstract][Full Text] [Related]
19. Effective inhibition of HCMV UL49 gene expression and viral replication by oligonucleotide external guide sequences and RNase P.
Zhang W; Li H; Li Y; Zeng Z; Li S; Zhang X; Zou Y; Zhou T
Virol J; 2010 May; 7():100. PubMed ID: 20482805
[TBL] [Abstract][Full Text] [Related]
20. [Modified Oligonucleotides for Guiding RNA Cleavage Using Bacterial RNase P].
Novopashina DS; Nazarov AS; Vorobjeva MA; Kuprushkin MS; Davydova AS; Lomzov AA; Pyshnyi DV; Altman S; Venyaminova AG
Mol Biol (Mosk); 2018; 52(6):1045-1054. PubMed ID: 30633247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
